Login

Dicerna Pharmaceuticals Inc SEC Filings

Filed On Filing
14 Feb 2022 SC 13G/A
10 Jan 2022 FORM 15-12B
30 Dec 2021 EFFECT
30 Dec 2021 EFFECT
30 Dec 2021 EFFECT
30 Dec 2021 EFFECT
29 Dec 2021 Form 4: Koppel Adam, Director

Disposed of 3,083,570 shares (Tender Offer) ($118M) · Disposed of 3,333 Restricted Stock Units (Disposition to Issuer) · Disposed of 130,000 Director Stock Option (Right to Buy) (Disposition to Issuer)

29 Dec 2021 Form 4: Zeng Ling, Chief Legal Officer & Sec'y

Disposed of 5,032 shares (Tender Offer) ($192K) · Disposed of 21,357 Restricted Stock Units (Disposition to Issuer) · Disposed of 127,945 Employee Stock Option (Right to Buy) (Disposition to Issuer)

29 Dec 2021 Form 4: Weissman James B, Chief Operating Officer & EVP

Disposed of 18,100 shares (Tender Offer) ($692K) · Disposed of 37,275 Restricted Stock Units (Disposition to Issuer) · Disposed of 707,078 Employee Stock Option (Right to Buy) (Disposition to Issuer)

29 Dec 2021 Form 4: Smith Cynthia, Director

Disposed of 3,333 shares (Tender Offer) ($127K) · Disposed of 3,333 Restricted Stock Units (Disposition to Issuer) · Disposed of 80,000 Director Stock Option (Right to Buy) (Disposition to Issuer)

29 Dec 2021 Form 4: Pagan Douglas W., Chief Financial Officer

Disposed of 7,775 shares (Tender Offer) ($297K) · Disposed of 26,625 Restricted Stock Units (Disposition to Issuer) · Disposed of 132,550 Employee Stock Option (Right to Buy) (Disposition to Issuer)

29 Dec 2021 Form 4: Kozin Marc D, Director

Returned 11,333 shares to the issuer ($433K) · Disposed of 3,333 Restricted Stock Units (Disposition to Issuer) · Disposed of 80,000 Director Stock Option (Right to Buy) (Disposition to Issuer)

29 Dec 2021 Form 4: Hoffman Stephen J, Director

Disposed of 16,157 shares (Tender Offer) ($618K) · Disposed of 3,333 Restricted Stock Units (Disposition to Issuer) · Disposed of 175,000 Director Stock Option (Right to Buy) (Disposition to Issuer)

29 Dec 2021 Form 4: Gray Patrick M., Director

Disposed of 3,333 shares (Tender Offer) ($127K) · Disposed of 3,333 Restricted Stock Units (Disposition to Issuer) · Disposed of 55,000 Director Stock Option (Right to Buy) (Disposition to Issuer)

29 Dec 2021 Form 4: Freed Martin I, Director

Disposed of 3,333 shares (Tender Offer) ($127K) · Disposed of 3,333 Restricted Stock Units (Disposition to Issuer) · Disposed of 130,000 Director Stock Option (Right to Buy) (Disposition to Issuer)

29 Dec 2021 Form 4: Fambrough Douglas, Director

Returned 231,431 shares to the issuer ($8.85M) · Disposed of 101,100 Restricted Stock Units (Disposition to Issuer) · Disposed of 2,707,235 Employee Stock Option (Right to Buy) (Disposition to Issuer)

29 Dec 2021 Form 4: Doberstein Stephen K, Director

Disposed of 3,333 shares (Tender Offer) ($127K) · Disposed of 3,333 Restricted Stock Units (Disposition to Issuer) · Disposed of 55,000 Director Stock Option (Right to Buy) (Disposition to Issuer)

29 Dec 2021 Form 4: Ciappenelli Robert D., Chief Strategy Officer

Disposed of 14,813 shares (Tender Offer) ($567K) · Disposed of 27,600 Restricted Stock Units (Disposition to Issuer) · Disposed of 407,644 Employee Stock Option (Right to Buy) (Disposition to Issuer)

29 Dec 2021 Form 4: Buchi J Kevin, Director

Disposed of 4,666 shares (Tender Offer) ($178K) · Disposed of 3,333 Restricted Stock Units (Disposition to Issuer) · Disposed of 102,000 Director Stock Option (Right to Buy) (Disposition to Issuer)

29 Dec 2021 Form 4: Brown Bob D, Chief Scientific Ofr., EVP R&D

Disposed of 2,367 shares (Tender Offer) ($90.5K) · Disposed of 37,275 Restricted Stock Units (Disposition to Issuer) · Disposed of 799,450 Employee Stock Option (Right to Buy) (Disposition to Issuer)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support